Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedram Rafiei

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Pharmaceutical Nanotechnology|September 27, 2017
Pharmacokinetic Consequences of PLGA Nanoparticles in Docetaxel Drug DeliveryPedram Rafiei, Azita Haddadi
Materials Science & Engineering. C, Materials for Biological Applications|September 11, 2019
A robust systematic design: Optimization and preparation of polymeric nanoparticles of PLGA for docetaxel intravenous deliveryPedram Rafiei, Azita Haddadi
International Journal of Nanomedicine|February 11, 2017
Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profilePedram Rafiei, Azita Haddadi
Drug Delivery|September 28, 2006
Pharmacokinetic consequences of pegylationMehrdad Hamidi, Amir Azadi, Pedram Rafiei
Advanced Drug Delivery Reviews|October 9, 2008
Hydrogel nanoparticles in drug deliveryMehrdad Hamidi, Amir Azadi, Pedram Rafiei
Expert Opinion on Drug Discovery|March 19, 2013
Designing PEGylated therapeutic molecules: advantages in ADMET propertiesMehrdad Hamidi, Pedram Rafiei, Amir Azadi
Critical Reviews in Therapeutic Drug Carrier Systems|October 9, 2013
A pharmacokinetic overview of nanotechnology-based drug delivery systems: an ADME-oriented approachMehrdad Hamidi, Amir Azadi, Pedram Rafiei, et al.
Journal of Pharmaceutical Sciences|March 5, 2011
Encapsulation of valproate-loaded hydrogel nanoparticles in intact human erythrocytes: a novel nano-cell composite for drug deliveryMehrdad Hamidi, Pedram Rafiei, Amir Azadi, et al.
Current Drug Discovery Technologies|July 3, 2019
Statins as the Controlling Agents for Non-Hodgkin's Lymphomas via Increasing the Casein Kinase 2 Interacting Protein-1: A HypothesisKimia Kazemi, Negin Mozafari, Hajar Ashrafi, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Pharmaceutical Nanotechnology|September 27, 2017
Pharmacokinetic Consequences of PLGA Nanoparticles in Docetaxel Drug DeliveryPedram Rafiei, Azita Haddadi
Materials Science & Engineering. C, Materials for Biological Applications|September 11, 2019
A robust systematic design: Optimization and preparation of polymeric nanoparticles of PLGA for docetaxel intravenous deliveryPedram Rafiei, Azita Haddadi
International Journal of Nanomedicine|February 11, 2017
Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profilePedram Rafiei, Azita Haddadi
Drug Delivery|September 28, 2006
Pharmacokinetic consequences of pegylationMehrdad Hamidi, Amir Azadi, Pedram Rafiei
Advanced Drug Delivery Reviews|October 9, 2008
Hydrogel nanoparticles in drug deliveryMehrdad Hamidi, Amir Azadi, Pedram Rafiei
Expert Opinion on Drug Discovery|March 19, 2013
Designing PEGylated therapeutic molecules: advantages in ADMET propertiesMehrdad Hamidi, Pedram Rafiei, Amir Azadi
Critical Reviews in Therapeutic Drug Carrier Systems|October 9, 2013
A pharmacokinetic overview of nanotechnology-based drug delivery systems: an ADME-oriented approachMehrdad Hamidi, Amir Azadi, Pedram Rafiei, et al.
Journal of Pharmaceutical Sciences|March 5, 2011
Encapsulation of valproate-loaded hydrogel nanoparticles in intact human erythrocytes: a novel nano-cell composite for drug deliveryMehrdad Hamidi, Pedram Rafiei, Amir Azadi, et al.
Current Drug Discovery Technologies|July 3, 2019
Statins as the Controlling Agents for Non-Hodgkin's Lymphomas via Increasing the Casein Kinase 2 Interacting Protein-1: A HypothesisKimia Kazemi, Negin Mozafari, Hajar Ashrafi, et al.
Pageof 1